About bml - BMLKF
BML, Inc. engages in the clinical and medical laboratory testing services for hospitals and clinics. It offers laboratory consignment work in the field of endocrinology, plasma protein, biochemistry, virology, and cellular immunity. The company was founded by Kenji Kondo on July 5, 1955 and is headquartered in Tokyo, Japan.
BMLKF At a Glance
BML, Inc.
5-21-3 Sendagaya
Tokyo, Tokyo 151-0051
| Phone | 81-3-3350-0111 | Revenue | 997.15M | |
| Industry | Medical/Nursing Services | Net Income | 51.42M | |
| Sector | Health Services | 2026 Sales Growth | 6.163% | |
| Fiscal Year-end | 03 / 2027 | Employees | 4,612 | |
| View SEC Filings |
BMLKF Valuation
| P/E Current | 16.171 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 18.826 |
| Price to Sales Ratio | 0.971 |
| Price to Book Ratio | 1.188 |
| Price to Cash Flow Ratio | 7.04 |
| Enterprise Value to EBITDA | 4.663 |
| Enterprise Value to Sales | 0.606 |
| Total Debt to Enterprise Value | 0.059 |
BMLKF Efficiency
| Revenue/Employee | 216,206.838 |
| Income Per Employee | 11,148.331 |
| Receivables Turnover | 5.927 |
| Total Asset Turnover | 0.826 |
BMLKF Liquidity
| Current Ratio | 2.488 |
| Quick Ratio | 2.369 |
| Cash Ratio | 1.664 |
BMLKF Profitability
| Gross Margin | 32.403 |
| Operating Margin | 6.937 |
| Pretax Margin | 7.977 |
| Net Margin | 5.156 |
| Return on Assets | 4.261 |
| Return on Equity | 6.166 |
| Return on Total Capital | 6.133 |
| Return on Invested Capital | 6.006 |
BMLKF Capital Structure
| Total Debt to Total Equity | 4.477 |
| Total Debt to Total Capital | 4.285 |
| Total Debt to Total Assets | 3.065 |
| Long-Term Debt to Equity | 2.483 |
| Long-Term Debt to Total Capital | 2.377 |